UnknownNot applicableNCT05009745
Preimplantation Genetic Screening in IVF Treatment
Studying Genetic infertility
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- King's College London
- Principal Investigator
- Sesh K Sunkara, MD, FRCOGKing's College London
- Intervention
- PGT-A Strategy(procedure)
- Enrollment
- 100 target
- Eligibility
- 35-42 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- King's Fertility, London, United Kingdom
Collaborators
Guy's and St Thomas' NHS Foundation Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05009745 on ClinicalTrials.govOther trials for Genetic infertility
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT07369362To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.MotilityCount aps
- ENROLLING BY INVITATIONNCT06419127Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation SequencingGattaca Genomics
- RECRUITINGNANCT06023472Microfluidic Chip vs Density Gradient Centrifugation on the Euploidy Rate of Pre-implantation Genetic TestingProfessor Ernest Hung-Yu Ng
- RECRUITINGNANCT06358547Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 YearsRigshospitalet, Denmark
- RECRUITINGNANCT06261671Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.ART Fertility Clinics LLC
- ACTIVE NOT RECRUITINGNANCT04744025Microfluidics Versus Gradient Centrifugation Effect on Euploidy RatesLawrence Engmann
- RECRUITINGNCT04528498Embryo Health StudyGenomic Prediction Inc.
- RECRUITINGNCT04477863Follow-up With Preimplantation Genetic Testing PatientsGenomic Prediction Inc.